Premium
Reply to ‘Comment on ‘Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomised controlled VaSera trial’ by Faconti et al .’
Author(s) -
Faconti Luca,
Cruickshank J. Kennedy,
Webb Andrew James
Publication year - 2019
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.13890
Subject(s) - nitrite , pi3k/akt/mtor pathway , medicine , blood pressure , muscle hypertrophy , downregulation and upregulation , endocrinology , cardiology , myocyte , pharmacology , nitrate , chemistry , apoptosis , biochemistry , organic chemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom